556 related articles for article (PubMed ID: 30047309)
1. Deciphering the binding of carbendazim (fungicide) with human serum albumin: A multi-spectroscopic and molecular modelling studies.
Siddiqui MF; Khan MS; Husain FM; Bano B
J Biomol Struct Dyn; 2019 Jun; 37(9):2230-2241. PubMed ID: 30047309
[TBL] [Abstract][Full Text] [Related]
2. Interactive association between RhoA transcriptional signaling inhibitor, CCG1423 and human serum albumin: Biophysical and in silico studies.
Kabir MZ; Ghani H; Mohamad SB; Alias Z; Tayyab S
J Biomol Struct Dyn; 2018 Aug; 36(10):2495-2507. PubMed ID: 28749242
[TBL] [Abstract][Full Text] [Related]
3. Exploring the combination characteristics of lumefantrine, an antimalarial drug and human serum albumin through spectroscopic and molecular docking studies.
Musa KA; Ridzwan NFW; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2021 Feb; 39(2):691-702. PubMed ID: 31913089
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic and computational evaluation on the binding of safranal with human serum albumin: Role of inner filter effect in fluorescence spectral correction.
Ali MS; Al-Lohedan HA
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Oct; 203():434-442. PubMed ID: 29894957
[TBL] [Abstract][Full Text] [Related]
5. Binding behavior of trelagliptin and human serum albumin: Molecular docking, dynamical simulation, and multi-spectroscopy.
Gan R; Zhao L; Sun Q; Tang P; Zhang S; Yang H; He J; Li H
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Sep; 202():187-195. PubMed ID: 29787915
[TBL] [Abstract][Full Text] [Related]
6. Molecular interaction study of an anticancer drug, ponatinib with human serum albumin using spectroscopic and molecular docking methods.
Tayyab S; Sam SE; Kabir MZ; Ridzwan NFW; Mohamad SB
Spectrochim Acta A Mol Biomol Spectrosc; 2019 May; 214():199-206. PubMed ID: 30780089
[TBL] [Abstract][Full Text] [Related]
7. Combination mode of antimalarial drug mefloquine and human serum albumin: Insights from spectroscopic and docking approaches.
Musa KA; Ridzwan NFW; Mohamad SB; Tayyab S
Biopolymers; 2020 Feb; 111(2):e23337. PubMed ID: 31691964
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive insight into the binding of sunitinib, a multi-targeted anticancer drug to human serum albumin.
Kabir MZ; Tee WV; Mohamad SB; Alias Z; Tayyab S
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jun; 181():254-263. PubMed ID: 28376387
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopy and molecular docking approach for investigation on the binding of nocodazole to human serum albumin.
Singh I; Luxami V; Paul K
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jul; 235():118289. PubMed ID: 32222625
[TBL] [Abstract][Full Text] [Related]
10. Interpretation of the binding interaction between bupropion hydrochloride with human serum albumin: A collective spectroscopic and computational approach.
M M; H D R
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Feb; 209():264-273. PubMed ID: 30414575
[TBL] [Abstract][Full Text] [Related]
11. Understanding the mode of binding mechanism of doripenem to human serum albumin: Spectroscopic and molecular docking approaches.
Maryam L; Sharma A; Azam MW; Khan SN; Khan AU
J Mol Recognit; 2018 Jul; 31(7):e2710. PubMed ID: 29603446
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the interaction between pyrogallol and human serum albumin by spectroscopic and molecular docking methods.
Roufegarinejad L; Amarowicz R; Jahanban-Esfahlan A
J Biomol Struct Dyn; 2019 Jul; 37(11):2766-2775. PubMed ID: 30052121
[TBL] [Abstract][Full Text] [Related]
13. Investigating the site selective binding of busulfan to human serum albumin: Biophysical and molecular docking approaches.
Siddiqi M; Nusrat S; Alam P; Malik S; Chaturvedi SK; Ajmal MR; Abdelhameed AS; Khan RH
Int J Biol Macromol; 2018 Feb; 107(Pt B):1414-1421. PubMed ID: 28987797
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic and molecular modeling approaches to investigate the binding of proton pump inhibitors to human serum albumin.
Pawar SK; Punith R; Naik RS; Seetharamappa J
J Biomol Struct Dyn; 2017 Nov; 35(15):3205-3220. PubMed ID: 27771990
[TBL] [Abstract][Full Text] [Related]
15. Characterization of sulfasalazine-bovine serum albumin and human serum albumin interaction by spectroscopic and theoretical approach.
Rahman N; Khalil N
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Nov; 300():122865. PubMed ID: 37269654
[TBL] [Abstract][Full Text] [Related]
16. Probing the binding mechanism of capecitabine to human serum albumin using spectrometric methods, molecular modeling, and chemometrics approach.
Mousavi SF; Fatemi MH
Bioorg Chem; 2019 Sep; 90():103037. PubMed ID: 31212179
[TBL] [Abstract][Full Text] [Related]
17. Probing the interaction of anticancer drug temsirolimus with human serum albumin: molecular docking and spectroscopic insight.
Shamsi A; Ahmed A; Bano B
J Biomol Struct Dyn; 2018 May; 36(6):1479-1489. PubMed ID: 28464730
[TBL] [Abstract][Full Text] [Related]
18. Probing the mechanism of interaction of metoprolol succinate with human serum albumin by spectroscopic and molecular docking analysis.
Pawar SK; Jaldappagari S
Luminescence; 2017 Sep; 32(6):942-951. PubMed ID: 28233399
[TBL] [Abstract][Full Text] [Related]
19. Glycation reduces the binding dynamics of aflatoxin B
Qureshi MA; Amir M; Khan RH; Musarrat J; Javed S
J Biomol Struct Dyn; 2023; 41(24):14797-14811. PubMed ID: 37021366
[TBL] [Abstract][Full Text] [Related]
20. Interaction and photo-induced cleavage studies of meropenem drug with human serum albumin using spectroscopic and molecular docking investigations.
Abdo Esmail SA; Shamsi M; Al-Asbahy WM
J Biomol Struct Dyn; 2019 Aug; 37(12):3282-3289. PubMed ID: 30088794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
